6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Joon‐Hyung Doh, Sang‐Hyun Kim et al.|The Lancet|2018Cited by 372
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Young Bin Song, Joo‐Yong Hahn et al.|Cardiology Journal|2021Cited by 23
Effectiveness of a Zotarolimus-Eluting Stent (Resolute Onyx<sup>TM</sup>) in Patients With Diffuse Long Coronary Artery Disease: Intravascular Ultrasound-guided vs. Angiography-guided Percutaneous Coronary InterventionJoon Ho Ahn, Youngkeun Ahn, Min Chul Kim et al.|Journal of Cardiovascular Intervention|2025Cited by 0